v3.25.4
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 14,565 $ 13,242
Short-term investments 0 447
Accounts receivable (net of allowance for doubtful accounts of $97 in 2025 and $89 in 2024) 11,775 10,278
Inventories (excludes inventories of $5,681 in 2025 and $4,193 in 2024 classified in Other assets - see Note 7) 6,658 6,109
Other current assets 10,518 8,706
Total current assets 43,516 38,782
Investments 956 463
Property, Plant and Equipment (at cost)    
Land 321 307
Buildings 17,983 16,360
Machinery, equipment and office furnishings 19,760 18,283
Construction in progress 9,166 7,984
Property, plant and equipment (at cost) 47,230 42,934
Less: accumulated depreciation 21,914 19,155
Property, plant and equipment, net 25,316 23,779
Goodwill 21,579 21,668
Other Intangibles, Net 26,681 16,370
Other Assets 18,818 16,044
Total Assets 136,866 117,106
Current Liabilities    
Loans payable and current portion of long-term debt 2,589 2,649
Trade accounts payable 4,404 4,079
Accrued and other current liabilities 14,468 15,694
Income taxes payable 4,726 3,914
Dividends payable 2,140 2,084
Total current liabilities 28,327 28,420
Long-Term Debt 46,750 34,462
Deferred Income Taxes 1,439 1,387
Other Noncurrent Liabilities 7,688 6,465
Merck & Co., Inc. Stockholders’ Equity    
Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2025 and 2024 1,788 1,788
Other paid-in capital 45,029 44,704
Retained earnings 73,075 63,069
Accumulated other comprehensive loss (4,287) (4,945)
Stockholders' equity before deduction for treasury stock 115,605 104,616
Less treasury stock, at cost: 1,102,476,756 shares in 2025 and 1,049,466,187 shares in 2024 62,999 58,303
Total Merck & Co., Inc. stockholders’ equity 52,606 46,313
Noncontrolling Interests 56 59
Total equity 52,662 46,372
Total Liabilities and Equity $ 136,866 $ 117,106